Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Return on Capital Employed (2018 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Return on Capital Employed for 6 consecutive years, with 0.68% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 43.0% year-over-year to 0.68%, compared with a TTM value of 0.68% through Oct 2025, up 43.0%, and an annual FY2025 reading of 0.88%, up 43.0% over the prior year.
  • Return on Capital Employed was 0.68% for Q4 2025 at VitaNova Life Sciences, up from 0.65% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.67% in Q1 2022 and bottomed at 0.97% in Q4 2022.
  • Average Return on Capital Employed over 4 years is 0.4%, with a median of 0.42% recorded in 2023.
  • The sharpest move saw Return on Capital Employed plummeted -125bps in 2023, then surged 62bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.97% in 2022, then soared by 143bps to 0.42% in 2023, then plummeted by -39bps to 0.25% in 2024, then soared by 167bps to 0.68% in 2025.
  • Business Quant data shows Return on Capital Employed for YJGJ at 0.68% in Q4 2025, 0.65% in Q3 2025, and 0.84% in Q2 2025.